Table 2.

Clinical characteristics of CLD patients treated at hospitals of Bahir Dar City, 2024 (n = 213)

Variable	Category	Frequency	Percent
Cause of CLD	Diagnosed as:
Viral (HBV = 117, HCV = 30)	Both HBV & HCV = 6, ALD = 2	141	60.0
HSS	ALD = 1, HBV = 3, HCV = 2	43	18.3
ALD	HBV = 4, HCV = 1	27	11.5
HMS	HCV = 4, HSS = 2	11	4.7
NAFLD		5	2.1
Others	TB = 2, Amoeba = 2, Drug = 4, ALD = 1	8	3.4
Complications	Ascites	138	64.8
	Portal hypertension	114	52.1
	Spontaneous bacterial peritonitis	13	6.1
	Hepatorenal syndrome	9	4.2
	Hepatic encephalopathy	6	2.8
Comorbid condition	No	161	75.6
	Yes*	52	24.4
Stages of CLD	Compensated	114	53.5
	Decompensated	99	46.5
End stage liver disease	HCC	60	60.6
	Cirrhosis	39	39.4
Albumin level	≥ 3.5 g/dl	75	35.2
	< 3.5 g/dl	138	64.8
APRI score	< 2	130	61.0
	≥ 2	83	39.0
FIB-4	Less likely (< 1.45)	59	27.7
	Indeterminate (1.45–3.25)	73	34.3
	More likely (> 3.25 points)	81	38.0
Took appropriate treatment and regimen for specific CLD cause	Yes	97	45.5
	No	116	54.5
Treatment duration	< 1 Years	22	10.3
	1–2 Years	119	55.9
	> 2 Years	72	33.8
Clinical and serological patient outcome	Improved	130	61.0
	Died (1 patient was on medication)	5	2.4
	Self-discharged (6 were on medication)	13	6.1
	No charge (31 took medication)	65	30.5

Key: FIB– fibroscan, HMS - hyper-reactive malarial splenomegaly syndrome, HSS - hepatosplenic schistosomiasis, *Diabetes mellitus [9], heart failure [3], hypertension [14], pneumonia [6], renal disorder [4], tuberculosis [6], venous thromboembolism [3], HIV/AIDS [2] and others; ^** no charge (66), self-discharged [13] and death [4]